• KU-55933 in Next-Generation Assays: Precision, Selectivity,

  2026-07-17

  Explore how KU-55933, a potent ATM kinase inhibitor, is redefining DNA damage response research through next-gen iPSC assay integration and advanced protocol control. Discover new insights distinct from prior reviews and practical guidance for high-impact cancer research.

• Latrunculin A in Virus–Host Cytoskeleton Research: Beyond In

  2026-07-16

  Explore how Latrunculin A, a reversible inhibitor of actin assembly, advances the study of virus–host cytoskeleton interactions. This article uniquely bridges proteomics, viral pathogenesis, and cell biology workflows, offering deeper insights for researchers.

• Olsalazine Sodium in Cancer and Mosquito Xenobiotic Research

  2026-07-16

  Olsalazine Sodium stands out as a dual-purpose tool in both cancer biology and vector physiology, enabling precise control of inflammation and xenobiotic transport studies. This article guides researchers through best-practice workflows, protocol optimizations, and troubleshooting strategies that leverage Olsalazine Sodium’s unique properties for reproducible, high-impact results.

• Biotin-16-UTP: Precision RNA Labeling for Advanced Assays

  2026-07-15

  Biotin-16-UTP enables sensitive, reproducible RNA labeling for streamlined detection, purification, and interaction studies. Discover proven protocol optimizations, troubleshooting strategies, and real-world applications that unlock its full potential in lncRNA research and beyond.

• Difloxacin HCl: Quinolone Antimicrobial Antibiotic for Advan

  2026-07-15

  Difloxacin HCl stands out as a potent quinolone antimicrobial antibiotic, uniquely enabling both rigorous microbial susceptibility testing and multidrug resistance reversal experiments. With reliable solubility and high purity, it empowers reproducible results in microbiology and oncology research alike.

• Trifluoperazine 2HCl in Neuropharmacology: Beyond Dopaminerg

  2026-07-14

  Explore Trifluoperazine 2HCl as a dopamine D2 receptor inhibitor with advanced applications in neuropharmacology, autophagy, and cancer research. This article offers a deeper analysis of mechanistic insights and protocol strategies for translational science.

• SGI-1027: DNA Methyltransferase Inhibitor Workflows in Cance

  2026-07-14

  SGI-1027 stands out as a DNA methyltransferase inhibitor, enabling robust, reproducible gene reactivation in cancer epigenetics research. This guide translates recent in vitro evaluation advances into practical protocols and troubleshooting strategies for leveraging SGI-1027 in precision cancer workflows.

• 17-AAG (Tanespimycin): Translating HSP90 Insights to Oncolog

  2026-07-13

  This thought-leadership article explores how 17-AAG (Tanespimycin), a synthetic HSP90 inhibitor, is reshaping translational cancer research. It details mechanistic underpinnings, experimental validation, and competitive positioning, while providing actionable protocol guidance and a visionary outlook. The discussion bridges molecular chaperone biology with translational strategy, highlighting how APExBIO’s 17-AAG empowers researchers to unravel complex oncogenic networks and advance therapeutic innovation.

• Sulfachloropyridazine: Applied Protocols for Microbial and I

  2026-07-13

  Sulfachloropyridazine stands out as a versatile sulfonamide antibacterial agent for both classic enzyme inhibition assays and advanced microbiome-infection models. This article details stepwise protocols, troubleshooting strategies, and translational lessons drawn from recent studies—including microbiota-metabolome profiling in Eimeria-infected chickens.

• n-Alkyl Modified Copper Ionophores Enable Precision Cupropto

  2026-07-12

  This study introduces a rational design strategy for copper ionophores incorporating n-alkyl chain modifications to optimize cuproptosis induction in cancer cells. The findings reveal how a C6-modified compound achieves potent, selective cuproptosis and antitumor immunity in triple-negative breast cancer, offering a new direction for metal-based cancer therapy.

• Ferrostatin-1 (Fer-1): Precision Control of Ferroptosis in C

  2026-07-10

  Explore the advanced role of Ferrostatin-1 (Fer-1) as a potent ferroptosis inhibitor in cancer biology research. This article uniquely dissects its application for selective targeting of cancer stem cells, integrating cutting-edge mechanistic insights and practical protocol guidance.

• Zolmitriptan: Optimized 5-HT1B Receptor Agonist in Migraine

  2026-07-09

  Harness the high purity and selective action of APExBIO’s Zolmitriptan for reproducible migraine and cluster headache studies. Discover advanced experimental workflows, troubleshooting strategies, and cross-study insights that elevate serotonin receptor pharmacology with actionable, protocol-driven guidance.

• Cisapride (R 51619): Reliable Cardiac Electrophysiology Rese

  2026-07-09

  This article addresses key laboratory challenges in cardiac electrophysiology and cytotoxicity screening, demonstrating how Cisapride (SKU B1198) from APExBIO ensures reproducible, high-sensitivity results. Drawing on recent evidence and validated workflows, it guides scientists in selecting, applying, and interpreting Cisapride for robust 5-HT4 receptor and hERG channel studies.

• Streptavidin-Cy3 for Superior Biotin Detection in Cancer Res

  2026-07-08

  Streptavidin-Cy3 sets the benchmark for high-sensitivity, quantitative biotin detection across immunohistochemistry, immunofluorescence, and flow cytometry. Its robust Cy3 fluorescence and irreversibly tight biotin binding empower reliable workflows, especially for probing cancer metastasis mechanisms.

• Lopinavir (ABT-378): Protocols and Innovations in HIV & Vira

  2026-07-08

  Lopinavir (ABT-378) stands at the forefront of antiviral research, offering unmatched potency for HIV protease inhibition and proven cross-pathogen efficacy. This article details advanced experimental workflows, troubleshooting strategies, and critical innovations—empowering researchers to maximize data quality in resistance and cross-viral studies.

449 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page